Thrombospondin type 1 domain-containing protein 7A (THSD7A) is a protein encoded in humans by the THSD7Agene.[5] It is a membrane glycoprotein expressed by podocytes in the kidney.[6]
THSD7A is a single-pass transmembrane protein with a large extracellular region containing 21 thrombospondin type 1 domains and a short intracellular tail.[6]
THSD7A is a target of autoantibodies in a subset of patients with membranous nephropathy. Its identification as a podocyte autoantigen in 2014 established THSD7A as a second antigen-associated form of the disease, after phospholipase A2 receptor 1.[6] Anti-THSD7A antibodies have been proposed as biomarkers for this condition.[7]
↑Jiang S, Jiang D, Lian Z, Huang X, Li T, Zhang Y (November 2024). "THSD7A as a Promising Biomarker for Membranous Nephrosis". Molecular Biotechnology. 66 (11): 3117–3135. doi:10.1007/s12033-023-00934-5. PMID37884765.